The progression of investigational products through a series of increasingly more sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for c
IN VITRO DIAGNOSTICS Mergers & Acquisitions ERBA Diagnostics Mannheim GMBH ERBA Diagnostics Inc. Escalon Medical Corp. Drew Scientific Inc. JAS Diagnostics Inc. ERBA Diagnostics Inc. , which is maj
Dr Jeffrey Stone has joined the board of directors at Uluru, a US speciality pharmaceutical company developing a portfolio of wound management and oral care products. Dr Stone is president of Wound Ca